Urba WJ - Search Results

1

Loss of interferon antibodies during prolonged continuous interferon-alpha 2a therapy in hairy cell leukemia.

Steis RG, Smith JW 2nd, Urba WJ, Venzon DJ, Longo DL, Barney R, Evans LM, Itri LM, Ewel CH. Steis RG, et al. Among authors: urba wj. Blood. 1991 Feb 15;77(4):792-8. Blood. 1991. PMID: 1704264 Free article.

2

Serum soluble IL-2 receptor as a tumor marker in patients with hairy cell leukemia.

Steis RG, Marcon L, Clark J, Urba W, Longo DL, Nelson DL, Maluish AE. Steis RG, et al. Blood. 1988 May;71(5):1304-9. Blood. 1988. PMID: 3129046 Free article.

3

Intensive therapy with cisplatin, interleukin-2 and interferon-alpha-2a in patients with metastatic melanoma. A phase II Study.

Sznol M, Steis RG, Smith JW 2nd, Janik JE, Sharfman WH, Urba WJ, Fenton RG, Creekmore SP, Beveridge J, Longo DL. Sznol M, et al. Among authors: urba wj. Online J Curr Clin Trials. 1992 Jul 1;Doc No 9:[3841 words; 32 paragraphs]. Online J Curr Clin Trials. 1992. PMID: 1343617 Clinical Trial.

4

Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.

Ewel CH, Urba WJ, Kopp WC, Smith JW 2nd, Steis RG, Rossio JL, Longo DL, Jones MJ, Alvord WG, Pinsky CM, et al. Ewel CH, et al. Among authors: urba wj. Cancer Res. 1992 Jun 1;52(11):3005-10. Cancer Res. 1992. PMID: 1591717 Clinical Trial.

5

Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.

Smith JW 2nd, Longo DL, Urba WJ, Clark JW, Watson T, Beveridge J, Conlon KC, Sznol M, Creekmore SP, Alvord WG, et al. Smith JW 2nd, et al. Among authors: urba wj. Blood. 1991 Oct 1;78(7):1664-71. Blood. 1991. PMID: 1912555 Free article.

6

The in vivo immunomodulatory effects of recombinant interferon gamma plus recombinant tumor necrosis factor-alfa.

Urba WJ, Kopp WC, Clark JW, Smith JW 2nd, Steis RG, Huber C, Coggin D, Longo DL. Urba WJ, et al. J Clin Oncol. 1991 Oct;9(10):1831-9. doi: 10.1200/JCO.1991.9.10.1831. J Clin Oncol. 1991. PMID: 1919633 Clinical Trial.

7

Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study.

Martin A, Nerenstone S, Urba WJ, Longo DL, Lawrence JB, Clark JW, Hawkins MJ, Creekmore SP, Smith JW 2nd, Steis RG. Martin A, et al. Among authors: urba wj. J Clin Oncol. 1990 Apr;8(4):721-30. doi: 10.1200/JCO.1990.8.4.721. J Clin Oncol. 1990. PMID: 2313337

8

Erythrocytosis in hairy cell leukaemia following therapy with interferon alpha.

Steis RG, VanderMolen LA, Lawrence J, Sing G, Ruscetti F, Smith JW 2nd, Urba WJ, Clark J, Longo DL. Steis RG, et al. Among authors: urba wj. Br J Haematol. 1990 May;75(1):133-5. doi: 10.1111/j.1365-2141.1990.tb02630.x. Br J Haematol. 1990. PMID: 2375913 No abstract available.

9

Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.

Urba WJ, Baseler MW, Kopp WC, Steis RG, Clark JW, Smith JW 2nd, Coggin DL, Longo DL. Urba WJ, et al. Blood. 1989 Jan;73(1):38-46. Blood. 1989. PMID: 2783373 Free article.

10

Diffuse osteosclerosis in hairy cell leukemia.

VanderMolen LA, Urba WJ, Longo DL, Lawrence J, Gralnick H, Steis RG. VanderMolen LA, et al. Among authors: urba wj. Blood. 1989 Nov 1;74(6):2066-9. Blood. 1989. PMID: 2804348 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters